Fierce Biotech March 19, 2024
After burning bright during the COVID-19 pandemic, Siemens Healthineers is now planning to shutter a relatively small unit within its larger diagnostics enterprise that had focused on molecular infectious disease tests.
The company’s Fast Track Diagnostics division and its about 100 employees maintain a portfolio of multiplex PCR tests, primarily sold in Europe, which includes assays for identifying a wide variety of pathogens such as respiratory infections, sexually transmitted diseases and childhood colds.
In a statement, Siemens Healthineers said the move follows a periodic strategic review of its operations, as well as significant declines in demand from the pandemic’s peak.
“Fast Track Diagnostics is a minor player in the molecular diagnostics space and represents a very small part of the...
Today's Sponsors
Today's Sponsor